Key result
Cardiovascular magnetic resonance imaging showed significant strong agreement with echocardiography in the detection of ejection fraction (ICC 0.714, p=0.006).
Why the study?
Cardiovascular magnetic resonance (CMR) offers detailed assessment of the mitral valve and its cardiac effects, but its diagnostic and evaluative role in mitral valve diseases warranted further study.
Does cardiovascular magnetic resonance (CMR) imaging provide comparable diagnostic evaluation to two-dimensional transthoracic echocardiography in patients with mitral valve diseases?
Observational (n=25)
Does cardiovascular magnetic resonance (CMR) imaging provide comparable diagnostic evaluation to two-dimensional transthoracic echocardiography in patients with mitral valve diseases?
Effect estimate: ICC 0.714
p-value: p=0.006
CMR demonstrates strong agreement with echocardiography for ejection fraction assessment and provides detailed evaluation of mitral valve morphology and regurgitation severity.
CMR may aid mitral valve assessment in small cohorts; leaves open routine adoption pending larger validation.
Background: Cardiovascular magnetic resonance (CMR) imaging has been considered an essential tool for the assessment of cases with mitral valve (MV) disease (MVD). It offers a detailed assessment of MV and its effects on the heart by offering accurate volumetric evaluation and myocardial scar evaluation. Aim: This study aimed to assess the role of CMR in diagnosis and evaluation of mitral valve diseases. Methods: This prospective study included 25 patients with mitral valve diseases. Radiological approaches were done at both Cardiology Department and Radiology Department and included two-dimensional transthoracic echocardiography (echo) (2D TTE) and CMR of the heart and proximal great vessels. Results: The mitral valve by MRI revealed mild MR in 36%, moderate MR in 4% and severe MR in 12%. Thickened MV leaflets in 28 %. MV prolapse 8%. Annular disjunction in 4% of the patients. Mild MR by Echocardiography was detected in 48%, moderate MR in 16% and severe in 8%. SAM of AML was shown in 4%. Mitral annular disjunction (MAD) was recorded in 4%. Thickened leaflets in 28%. There was mild agreement between MRI and echo in detection of LVOT (k=0.359, P=0.019).There was a significant strong agreement between MRI and echocardiography in detection of ejection fraction (Interclass correlation coefficient was 0.714) (p=0.006). Conclusion: CMR played an essential role in terms of valvular heart disease (VHD). It enabled the visual analysis of valvular shape and function. CMR as a noninvasive imaging modality played an important role to assess mitral regurgitation (MR) severity and mitral regurgitant volume (MRV).
No takes yet. Share an insight, caveat, or question.
A 2025 study conducted an observational in Mitral valve diseases (n=25). Cardiovascular magnetic resonance (CMR) imaging vs. Two-dimensional transthoracic echocardiography (2D TTE) was evaluated on Agreement between MRI and echocardiography in detection of ejection fraction (ICC 0.714, p=0.006). Cardiovascular magnetic resonance imaging showed significant strong agreement with echocardiography in the detection of ejection fraction (ICC 0.714, p=0.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: